NCT03382600 2024-06-11
KEYNOTE-659
Merck Sharp & Dohme LLC
Phase 2 Completed
Clinical Trials
3 trialsNCT00429858 2020-09-18
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
University of California, San Francisco
Phase 2 Terminated
NCT00438100 2015-05-29
Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer
Japan Breast Cancer Research Network
Phase 2 Completed